These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6072575)

  • 61. Double blind cross-over study of the inotropic influence of Tiprenolol (DU21445) and propranolol in patients with ischaemic heart disease.
    Yan V; Sloman G
    Aust N Z J Med; 1973 Oct; 3(5):467-73. PubMed ID: 4149632
    [No Abstract]   [Full Text] [Related]  

  • 62. Effects of beta-adrenergic blockade on the hemodynamic response to carotid sinus reflexes.
    Lacroix E; Demeester G; Leusen I
    Arch Int Pharmacodyn Ther; 1968 Oct; 175(2):447-63. PubMed ID: 5702960
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs].
    Campus S; Rappelli A; Fabris F; Mathis I
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1847-51. PubMed ID: 5602829
    [No Abstract]   [Full Text] [Related]  

  • 64. The comparative hemodynamic effects of propranolol in chronically instrumented puppies and adult dogs.
    Driscoll DJ; Fukushige J; Lewis RM; Hartley CJ; Entman MJ
    Biol Neonate; 1982; 41(1-2):8-15. PubMed ID: 7066441
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interactions of sympathomimetic and sympatholytic agents in normotensive and hypertensive subjects.
    Kato M; Komata KE
    Tohoku J Exp Med; 1969 Mar; 97(3):213-31. PubMed ID: 5789718
    [No Abstract]   [Full Text] [Related]  

  • 66. Cardiac arrhythmias produced by interaction of ouabain and beta-receptor stimulation.
    Raper C; Wale J
    Eur J Pharmacol; 1969; 6(3):223-34. PubMed ID: 5805364
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparative haemodynamic studies with mepindolol-sulphage (SH E 222) and propranolol (Inderal, Dociton) in the isoproterenol test.
    Bonelli J
    J Int Med Res; 1978; 6(4):317-25. PubMed ID: 689291
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of beta adrenergic receptor blockade on skeletal muscle vasodilatation produced by isoxsuprine and nylidrin.
    Manley ES; Lawson JW
    Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):239-50. PubMed ID: 4387239
    [No Abstract]   [Full Text] [Related]  

  • 70. Hemodynamic response to exercise after propranolol in normal subjects.
    Cumming GR; Carr W
    Can J Physiol Pharmacol; 1966 May; 44(3):465-74. PubMed ID: 5914366
    [No Abstract]   [Full Text] [Related]  

  • 71. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 72. [Local propranolol blocking of the beta-adrenergic receptors of the sinoatrial node during intravenous infusion of isoproterenol. Experimental research].
    Mezzacapo B; Massaria E; Di Fabio D
    Minerva Cardioangiol; 1969 Dec; 17(12):1074-9. PubMed ID: 4392066
    [No Abstract]   [Full Text] [Related]  

  • 73. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
    [No Abstract]   [Full Text] [Related]  

  • 74. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 76. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 77. Efficacy of beta-adrenergic blocking agents in inducing histamine sensitivity in mice.
    Bergman RK; Munoz J
    Nature; 1968 Mar; 217(5134):1173-4. PubMed ID: 4384489
    [No Abstract]   [Full Text] [Related]  

  • 78. The effect of propranolol and the dextro and laevo isomers of H 56-28 upon ouabain-induced ventricular tachycardia in unanaesthetized dogs.
    Duce BR; Garberg L; Johansson B
    Acta Pharmacol Toxicol (Copenh); 1967; 25():41-9. PubMed ID: 6072571
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.
    Farmer JB; Levy GP
    Br J Pharmacol; 1968 Sep; 34(1):116-26. PubMed ID: 5676002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.